Objectives To investigate spatial heterogeneity of white matter lesions or hyperintensities (WMH).
White matter lesions or hyperintensities (WMH) are common findings in older adults, characterized by a hyperintense signal on T2-weighted MRIs. WMH are considered a type of sporadic small vessel disease 1 and are associated with gray matter atrophy in Alzheimer disease (AD)-related regions, 2, 3 cognitive decline, and increased risk of dementia. 4 WMH have therefore received increasing attention as a contributor to brain aging, neurodegeneration, and dementia. In addition, there is mounting evidence that the spatial location of WMH may have distinct neuropathologic and clinical associations. [5] [6] [7] [8] [9] [10] [11] Despite evidence indicating differential etiology of location of WMH and increased likelihood of dementia depending on the spatial distribution, 12 most studies measure total WMH burden. Only a few studies have considered differential regionspecific WMH associations 7, 11, [13] [14] [15] ; however, such studies use empirically defined WMH categories. Therefore, we compute data-driven WMH definitions, by modeling inherent WMH covariation patterns in the MRIs, 16 via nonnegative matrix factorization. 17, 18 We tested the hypothesis that WMH occurrence exhibits spatial heterogeneity, rather than simply being a process of uniformly increasing volume of abnormalappearing tissue. We aimed to deepen our understanding of the spatial heterogeneity of WMH and their progression with age, as well as to investigate their correlates with clinical and genetic risk factors, brain atrophy, and cognitive decline.
Methods

Study of Health in Pomerania participants
We included 1,836 participants encompassing a wide age range (22-84 years) from the Study of Health in Pomerania (SHIP) cohort, led by the Institute for Community Medicine at the University Medicine Greifswald, Germany. The SHIP project consists of 2 independent cohorts, SHIP-2 and SHIP-TREND. SHIP participants were recruited using a 2-stage stratified and cluster sampling scheme to represent a sample between 20 and 79 years. First, regional communities were selected; second, residence registries were used to draw a random representative sample. Characteristics of the included and excluded samples are provided in table 1. An outline of the exclusion criteria is presented in the online data available from Dryad (figure e-1, doi.org/10.5061/dryad.k6k42cq).
Data assessment and laboratory work in SHIP 19 were described previously in more detail by Habes et al. 3, 20 and are presented in the online data available from Dryad (section e-1, doi.org/10.5061/dryad.k6k42cq). In our analysis, we included the following variables: (1) smoking, (2) education, (3) systolic blood pressure, (4) glycosylated hemoglobin, (5) waist circumference, (6) antihypertensive medication use, (7) antidiabetic medication use, (8) lipid-lowering medication use, (9) total cholesterol, (10) low-density lipoprotein, (11) high-density lipoprotein, (12) intima-media thickness (available for n = 1,817), and (13) AD polygenic risk score (available for n = 985), which was calculated as described in data available from Dryad (section e-2). Determination of participants with possible cognitive impairment in SHIP has been described in data available from Dryad (section e-3).
Baltimore Longitudinal Study of Aging participants
The Baltimore Longitudinal Study of Aging (BLSA) is a longrunning study of aging led by the National Institute on Aging in Baltimore, MD. BLSA participants are a volunteer sample of community-dwelling individuals. Specific recruitment strategies have varied over time, but all participants meet health criteria at entry. The neuroimaging substudy of the BLSA has been described previously. 21 We included in this study 307 cognitively normal and mild cognitive impairment participants with 747 observations to examine longitudinal associations with cognition in an independent aging cohort. Participants of the BLSA have received MRI and cognitive testing at the same visit. Every participant had at least 2 observations of WMH and complete cognition information, including diagnostic designation based on cognitive status. Table 2 presents the characteristics of BLSA at baseline. We included the following neuropsychological scores for the BLSA sample: (1) the Benton Visual Retention Test for visual memory assessment; (2) Trail Making Test, Parts A and B, assessing attention and executive function, respectively; and (3) the California Verbal Learning Test.
Standard protocol approvals, registrations, and patient consents The ethics committee of the Medical Faculty of the University of Greifswald approved the SHIP study. All participants provided written informed consent. The National Institute of Environmental Health Sciences institutional review board approved the BLSA protocol, and written informed consent was obtained at each study visit.
Image acquisition and preprocessing Imaging parameters were described by Hegenscheid et al. 22 for SHIP and by Venkatraman et al. 23 for BLSA; additional details are given in data available from Dryad (section e-4, doi. org/10.5061/dryad.k6k42cq). Image analysis was performed using T1-weighted and fluid-attenuated inversion recovery brain MRIs, described in more detail in data available from Dryad (section e-5). Briefly, an automated multimodal method was used to segment WMH, which were then aligned to a common template space. Structural T1-weighted MRIs for SHIP were processed using the protocols of the ENIGMA (Enhancing Neuro Imaging Genetics Through Meta Analysis) consortium for the calculation of cortical thickness (data available from Dryad, section e-5).
Identifying covariance components WMH components (WMHCs) were identified using a nonnegative matrix factorization method, which summarizes complex multivariate patterns of covariation in the data with a predefined number of nonnegative components 17 (data available from Dryad, section e-6, doi.org/10.5061/ dryad.k6k42cq). The method was applied to the whole SHIP sample (n = 1,836) to derive a set of WMHCs. Participant-specific coefficients for each component were then calculated for both the SHIP and the BLSA cohorts to quantify corresponding WMH burden within each component. 
Statistical analysis
More details on the statistical analysis can be found in data available from Dryad (section e-7, doi.org/10.5061/dryad. k6k42cq). We examined relationships of the identified components with age in SHIP using linear regression models independently for each component, with age categorized in decades. In SHIP, cross-sectional WMHC trend lines were computed independently for each component using a linear regression model that included age and age 2 as predictors. For longitudinal temporal trends in BLSA, we used linear mixedeffects models with similar predictors. Significance of the differences between trend lines was assessed through permutation testing (data available from Dryad, section e-8). To assess possible staging of the WMH progression, we estimated a model of regional WMH progression based on the frequency of regional WMH presence across participants, similar to the method by Grothe et al. 24 In this analysis, each WMHC for each participant was categorized as WMH "present" or "absent," according to a fixed threshold estimated from the total WMH volume for the complete sample.
We performed vertex-wise analysis of the cortical thickness in SHIP (n = 1,836) to inspect the relationship to each component. Results were considered significant if they survived clusterwise correction for multiple comparisons at p < 0.05. We assessed the cross-sectional association between risk factors and WMHCs in the whole SHIP sample (n = 1,836) using a linear regression model for each component as outcome (resulting in 4 models). Similarly, we investigated cross-sectional associations of the 4 WMHCs with the AD polygenic risk score in the whole SHIP sample with available genotyping (n = 985) and in those older than 65 years (n = 189). All regression models using the whole age range SHIP sample were adjusted for age, age 2 , sex, education, and SHIP subcohort. 25 Models were Bonferronicorrected by factor 4. Finally, we used independent linear mixed-effect models to investigate associations of longitudinal change in WMHCs with cognitive scores as outcome and WMHCs as predictors (one model at a time, resulting in 16 models) in BLSA (n = 307 and 747 observations). All models were adjusted for age, age 2 , sex, educational level, and scanner type. Random slopes with age effect were included in the models in addition to random intercepts. Models were Bonferroni-corrected by factor 16 . In all models, we applied a cubic root transformation on the WMHC values to normalize their distribution. Results were considered statistically significant if the 2-sided p value was <0.05 after Bonferroni correction. Analyses were performed using R software version 3.1. 26 
Data availability
Data from SHIP are available after data application and signature of a data transfer agreement. The data dictionary and the online application form are available at: fvcm.med.uni-greifswald.de/ dd_service/data_use_intro.php. Involving a local collaborative partner to facilitate the application process is recommended.
Data from the BLSA are available on request from the BLSA website (blsa.nih.gov). All requests are reviewed by the BLSA Data Sharing Proposal Review Committee and are also subject to approval from the NIH institutional review board.
Results
Spatial distribution of WMH covariance components
In the SHIP sample (n = 1,836), we identified 4 WMH covariance components (figure 1, A and B), selected according to previously defined criteria (data available from Dryad, section e-6 and figure e-2, doi.org/10.5061/dryad.k6k42cq). The robustness of the final components was validated through reproducibility experiments using random half-splits of the SHIP sample with similar age and sex distributions (data available from Dryad, section e-6 and figure e-3). We quantified the extent to which these components were overlapping between the 2 splits by calculating the inner product of matching component pairs (data available from Dryad, table e-1). The median overlap value was 88%, showing highly Neurology.org/N reproducible results. From the 4 components, the first 3 surrounded the ventricles and specified as periventricular posterior (WMHC-post., blue in figure 1), periventricular frontal (WMHC-fron., green in figure 1), and periventricular dorsal (WMHC-dors., yellow in figure 1) regions. The fourth component included the deep WMH and was located laterally to the other 3 components (WMHC-deep, red in figure 1 ). We applied the structural covariance approach on the BLSA baseline sample (n = 307) to assess the sensitivity of the approach toward different population characteristics (data available from Dryad, figure e-4). The median overlap value between components derived from SHIP vs BLSA was 66%, with the highest overlap in the frontal WMHC (data available from Dryad, table e-2).
Associations with age
We examined relationships of the identified components with age. Table 3 shows the differential association of WMHC-fron. with age in SHIP, as it was present from fifth decade of life, while other components were present from the sixth decade. Cross-sectional and longitudinal temporal trends of the 4 WMHCs are shown in figure 1, C and D.
Supplementary analysis using permutation tests showed that the components had differential trend lines except between the WMHC-dors. and WMHC-deep components crosssectionally (data available from Dryad, section e-7 and table e-3, doi.org/10.5061/dryad.k6k42cq). Figure 2 shows some hierarchical nesting across participants, both in SHIP and BLSA, as well as participants with distribution profiles that do not conform to the model, particularly in SHIP (approximately 10%) (more details in data available from Dryad, section e-9).
Associations with cortical thickness
We found widespread regional cortical atrophy associations in SHIP for all 4 WMHCs (n = 1,836, figure 1E ). Gray matter decrease in the frontal, inferior parietal, and temporal cortex was more pronounced in association with the WMHC-fron. compared to the other components (data available from Dryad, section e-10, doi.org/10.5061/dryad.k6k42cq). We quantified the overlap in cortical atrophy regions associated with each of the 4 WMHCs. The amount of overlap between 2 regions is measured using their Dice coefficient (data available from Dryad, table e-4).
Associations with vascular risk factors, AD polygenic risk score, and cognition We found significant cross-sectional associations of WMHCs with vascular risk factors in the SHIP sample (n = 1,836, table 4). Specifically, intima-media thickness was significantly associated with WMHC-dors.; smoking was associated with the same component, in addition to WMHC-post. and WMHCdeep; higher blood pressure was associated with WMHCfron.; and female sex was associated with more WMHC-fron. After exclusion of individuals with possible cognitive impairment (n = 178), only the associations of WMHC-fron. with higher blood pressure and WMHC-post. with smoking The models were adjusted for sex, smoking, education, systolic blood pressure, glycosylated hemoglobin, waist circumference, antihypertensive medication use, antidiabetic medication use, lipid-lowering medication use, total cholesterol, low-density lipoprotein, high-density lipoprotein, intima-media thickness, and SHIP substudy cohort. 
Discussion
The current study expands on previous studies that have used total WMH measures by investigating spatial heterogeneity of WMH in large aging cohorts. We identified spatially heterogeneous components of WMH and demonstrated that these components displayed differential associations with age, risk of neurodegeneration, and vascular risk factors. Of note, WMHC-fron. was evident about 2 decades earlier than the remaining components. WMHC-fron. also showed stronger association with blood pressure and cortical atrophy. Only WMHC-dors. showed associations with AD genetic risk and with longitudinal cognitive decline. The observed spatial heterogeneity is potentially related, in part, to underlying normal heterogeneity in brain anatomy and physiology, as well as heterogeneity of pathophysiologic processes that drive the appearance of these WMH and may have different implications for cognitive outcomes.
WMH have been commonly subdivided into deep and periventricular WMH subclasses. 27, 28 However, the definition of these subdivisions has been inconsistent with a generally poor overlap in WMH subclass ratings. 29 It has been suggested that shape provides complementary information for distinguishing WMH subcomponents. 30 Another suggestion was to use a simple "distance from the ventricles" measure for the classification into deep and periventricular WMH, but the definition of this distance was variable, arbitrary, and without consensus. 6, 31 Capitalizing on a large sample from the general population and a datadriven method, we systematically categorized WMH without use of prior arbitrary knowledge for defining regional boundaries; rather, those boundaries were detected through clusters of high covariation of WMH occurrence across individuals.
Our data-driven approach separated the deep WMH from the periventricular ones (WMHC-deep vs others) in agreement with suggestions in the literature. Of note, the periventricular WMH were also partitioned into posterior and frontal components (WMHC-post. and WMHC-fron.), as well as a more dorsal component (WMHC-dors.). Therefore, we found higher variation in periventricular WMH compared to the deep WMH, a finding not reported in the literature before.
With the nonnegative matrix factorization approach, we assume that the WMH occurrence can be decomposed into highly nonoverlapping parts, where each part groups elements that change in a coordinated fashion across the population. As typical for all factorization methods, it is important to specify the number of components to be extracted. This is the only decision that we have imposed. We determined this number by rigorously examining the coverage of total WMH load and by choosing the largest coverage (data available from Dryad, section e-6, doi.org/10.5061/dryad.k6k42cq). Assessment of the robustness of the final components through reproducibility experiments, using random half-splits of the SHIP sample, showed that the covariance approach would perform consistently in similar populations. The components derived from the BLSA baseline sample (n = 307) were reproducible to a lesser extent, with 66% overlap between components derived from SHIP vs BLSA (data available from Dryad, table e-2). The highest overlap was obtained for the frontal component (91%), maybe because of the existence of similar factors deriving its appearance in both cohorts. However, differences in population characteristics between SHIP and BLSA such as mean age or education and other deriving factors would yield modest overlap in other components.
We observed differential cross-sectional trend lines and longitudinal trajectories, with statistically significant pairwise differences between components, supported by permutation tests. Of note, WMHC-fron. appeared at an earlier age (significant from the fifth decade of life [table 3 ]) compared to the other components (significant from the sixth decade of life). Prefrontal white matter is most susceptible to the influence of age, 32 which might explain why WMHC-fron. was present at earlier age. WMHC-fron. also had a less exponential growth or acceleration with age compared to WMHC-post. and WMHC-dors.; perhaps this result can be reflected with stronger associations between posterior WMH with neurodegenerative processes that tend to accelerate later in life. Although some insights can be taken from our findings regarding AD polygenic risk score and cognition, unfortunately our data cannot provide causal evidence for this result, and further studies are required.
Our results showed that the data-driven components are representing staging as well as different etiologies in WMH appearance. These results are largely expected. The fact that these components were derived from SHIP, which is sampled from the general population with a wide age range (22-84 years), hints to the heterogeneous nature of WMH. Previous research has shown involvement of inflammatory, vascular, and neurodegenerative diseases in the appearance of WMH. Such conditions are expected to contribute to WMH volume in our sample, according to their prevalence in the general population from the region.
To our knowledge, only one study showed any differential association between regional WMH volume and gray matter atrophy. 33 An interesting finding of our analysis was that the WMHC-fron. component displayed considerably more widespread associations with cortical thinning, in particular in AD-related regions such as the anterior temporal lobe, compared to the other 3 components, especially WMHC-deep and WMHC-post. (figure 1). One explanation could be that WMHC-fron. appeared earlier in life and also showed strong association with blood pressure (tables 3 and 4) . It has been demonstrated that frontal WMH were more likely to be present in patients with poststroke vascular dementia compared to healthy controls, and the frontal white matter was more affected than the temporal white matter. 34 Our finding of early association of WMHC-fron. with age, increased blood pressure, and more pronounced atrophy is further suggestive of the importance of frontal WMH with respect to neurodegeneration and possibly vascular cognitive dysfunction. Further research is needed to determine whether the WMHC-fron. differentially predicts future vascular dementia.
The posterior periventricular, dorsal, and deep white matter components were associated with smoking. The mechanisms for the association between smoking and posterior periventricular WMH and deep WMH can be potentially explained by different nicotine receptor distribution in the brain. 35 The link between intima-media thickness and WMH may primarily reflect shared risk factors such as smoking. 36 While associations between these risk factors and regional WMH have been reported previously, 37, 38 a contribution of our analysis lies in the application of a data-driven method, which "categorizes" those changes across the population together. Few MRI studies have such statistical power, with a population-based sample and a very high standardization protocol.
A recent study showed that WMH volume is significantly elevated among individuals with autosomal dominant genetic mutations for AD. These changes are most pronounced in posterior periventricular regions. 39 In our study, only the periventricular dorsal component showed a significant association with the AD polygenic risk score in individuals older than 65 years that survived Bonferroni correction (table 4) . Because the prevalence of sporadic AD increases rapidly after the age of 65, our findings might reflect a contribution of AD pathology to the development of WMH.
A very striking result in our analysis was that WMH-dors., which showed a significant association with the AD polygenic risk score after the age of 65 years, was also significantly associated with longitudinal cognitive decline in the validation sample BLSA. This finding is further suggestive of a potential role of impairment in cognitive abilities and dementia-related degeneration with focal appearance of WMH in periventricular dorsal regions.
Studies utilizing advanced structural covariance analysis for systematically investigating spatial heterogeneity of WMH are rare. A few recent studies used a similar methodology for examining regional structural covariance in aging populations. 16 However, these studies were limited to analysis of gray matter. Another strength of our work is the rich cohorts included. The large population-based sample in SHIP, which spans a wide age range, allowed us to reliably define WMH patterns and to study their correlates. The BLSA cohort provided a valuable longitudinal sample to examine trajectories of WMHCs.
Despite the above strengths, certain limitations should be noted. First, some modifiable risk factors, such as dietary factors (e.g., salt or sugar intake) and inflammation, were not included in the study. Second, our analysis did not include periventricular spaces, or further small vessel disease subtype assessment, and those should be considered in future research. Third, although associations between WMHCs and risk factors or AD polygenic risk score are suggestive and reasonable, such correlational analyses do not establish causality and are potentially limited by the high correlation between the components and total WMH volume (data available from Dryad, table e-8 and figure e-5, doi.org/10. 5061/dryad.k6k42cq). Fourth, The SHIP participants did not have complete cognitive testing. Therefore, some brain changes in the SHIP sample are more specific to aging, but also others might be driven by unrecognized changes and that might represent the initial impairment in people with vascular cognitive disorder. Fifth, several of the findings were not robust to exclusion of relatively few participants with (possible) cognitive impairment; as a result, a small proportion of participants may be primarily deriving some of the observed associations. Sixth, our strict quality control criteria resulted in a high number of scans excluded in SHIP, which might lead to potential bias and less generalizability of our results. Finally, The BLSA sample with available T1 and fluid-attenuated inversion recovery scans that we used for studying longitudinal associations was rather small. Repeated assessments continue in BLSA, and future studies should consider larger samples with longer follow-up intervals.
Our study indicates that WMH appearance follows systematic and co-occurring regional patterns. We found an early involvement of the periventricular frontal regions, with strong associations with blood pressure and more pronounced cortical atrophy through the adult lifespan. The periventricular dorsal component showed associations with AD polygenic risk score and cognitive decline, as well as later appearance in the aging brain. Our findings support the hypothesis that the appearance of WMH follows age-and disease-dependent regional distribution patterns, potentially influenced by differential underlying pathophysiologic mechanisms, and possibly with different implications for vascular risk factors as well as neurodegenerative and cognitive outcomes.
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